Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-12-07
2000-04-18
Fonda, Kathleen K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514849, 514853, A61K 3144
Patent
active
060515856
ABSTRACT:
An oral once-per-day single dosage unit for treating the symptoms of rhinitis expertly formulated with a nasal decongestant and antihistamine. Preferably, the antihistamine is non-sedating.
REFERENCES:
patent: 5314697 (1994-05-01), Kwan et al.
Bronsky et al. The Journal of Allergy and Clinical Immunology Aug. 1995, 96(2), 139-147.
Weinstein Alan M.
Weinstein Robert E.
Deleault, Esq. Robert R.
Fonda Kathleen K.
LandOfFree
Single-dose antihistamine/decongestant formulations for treating does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Single-dose antihistamine/decongestant formulations for treating, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Single-dose antihistamine/decongestant formulations for treating will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2336637